Toward a crystal-clear view of lithium's site of action.
Baraban
J M
JM
Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2185.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007294:Inositol / Q000378:metabolism; D007295:Inositol Phosphates / Q000378:metabolism*; D008094:Lithium / Q000494:pharmacology* / Q000627:therapeutic use* / Q000633:toxicity; D008563:Membrane Lipids / Q000378:metabolism; D010716:Phosphatidylinositols / Q000378:metabolism*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism
D007295:Inositol Phosphates; D008563:Membrane Lipids; D010716:Phosphatidylinositols; D007294:Inositol; D008094:Lithium; D010744:Phosphoric Monoester Hydrolases; C021822:myo-inositol-1 (or 4)-monophosphatase